Angelini acquires ThermaCare brand from GSK

11 March 2020 - Deborah Wilkes

Premium

Italy’s Angelini Pharma has acquired the global business rights – excluding North America – to GlaxoSmithKline’s (GSK’s) ThermaCare pain-management brand.

Click tags below for more information on topics:

Angelini GlaxoSmithKline

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: